Ye F - Search Results

1

RETRACTED: Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus.

Gao Q, Zhou J, Huang X, Chen G, Ye F, Lu Y, Li K, Zhuang L, Huang M, Xu G, Wang S, Ma D. Gao Q, et al. Among authors: ye f. Mol Ther. 2006 May;13(5):928-937. doi: 10.1016/j.ymthe.2005.12.009. Epub 2006 Feb 3. Mol Ther. 2006. Retraction in: Mol Ther. 2023 Feb 1;31(2):600. doi: 10.1016/j.ymthe.2022.12.015 PMID: 16459149 Free article. Retracted.

2

[Silencing of cell cycle checkpoint kinase gene enhances cisplatin-induced apoptosis of lung cancer cells].

Ye F, Xie DX, Lu YP, Gao QL. Ye F, et al. Zhonghua Zhong Liu Za Zhi. 2009 Nov;31(11):804-9. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20137342 Chinese.

3

[Down-regulation of Chk1/Chk2 gene expression increases apoptosis in irradiated HeLa cells and its mechanism].

Gao QL, Ye F, Xing H, Xie DX, Lu YP, Zhou JF, Ma D. Gao QL, et al. Among authors: ye f. Zhonghua Zhong Liu Za Zhi. 2009 Mar;31(3):178-82. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615254 Chinese.

4

Therapeutic targeting of EGFR in malignant gliomas.

Ye F, Gao Q, Cai MJ. Ye F, et al. Expert Opin Ther Targets. 2010 Mar;14(3):303-16. doi: 10.1517/14728221003598948. Expert Opin Ther Targets. 2010. PMID: 20148717 Review.

5

Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer.

Ji T, Gong D, Han Z, Wei X, Yan Y, Ye F, Ding W, Wang J, Xia X, Li F, Hu W, Lu Y, Wang S, Zhou J, Ma D, Gao Q. Ji T, et al. Among authors: ye f. Cancer Lett. 2013 Dec 1;341(2):231-9. doi: 10.1016/j.canlet.2013.08.022. Epub 2013 Aug 17. Cancer Lett. 2013. PMID: 23962558

6

[PTEN coding product: a marker for tumorigenesis and progression of endometrial carcinoma].

Gao QL, Ye F, Li J, Xing H, Lu YP, Ma D. Gao QL, et al. Among authors: ye f. Ai Zheng. 2003 Jun;22(6):640-4. Ai Zheng. 2003. PMID: 12948417 Chinese.

7

Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma.

Gao Q, Ye F, Xia X, Xing H, Lu Y, Zhou J, Ma D. Gao Q, et al. Among authors: ye f. J Huazhong Univ Sci Technolog Med Sci. 2009 Feb;29(1):59-63. doi: 10.1007/s11596-009-0112-6. Epub 2009 Feb 18. J Huazhong Univ Sci Technolog Med Sci. 2009. PMID: 19224164

8

Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma.

Gao Q, Lei T, Ye F. Gao Q, et al. Among authors: ye f. Expert Opin Investig Drugs. 2013 Aug;22(8):1023-40. doi: 10.1517/13543784.2013.806484. Epub 2013 Jun 4. Expert Opin Investig Drugs. 2013. PMID: 23731170 Review.

9

C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation.

Liu D, Zhang XX, Li MC, Cao CH, Wan DY, Xi BX, Tan JH, Wang J, Yang ZY, Feng XX, Ye F, Chen G, Wu P, Xi L, Wang H, Zhou JF, Feng ZH, Ma D, Gao QL. Liu D, et al. Among authors: ye f. Nat Commun. 2018 Apr 30;9(1):1739. doi: 10.1038/s41467-018-03590-5. Nat Commun. 2018. PMID: 29712898 Free PMC article.

10

C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer.

Tan J, Zheng X, Li M, Ye F, Song C, Xu C, Zhang X, Li W, Wang Y, Zeng S, Li H, Chen G, Huang X, Ma D, Liu D, Gao Q. Tan J, et al. Among authors: ye f. Oncogene. 2021 Jun;40(22):3845-3858. doi: 10.1038/s41388-021-01788-4. Epub 2021 May 8. Oncogene. 2021. PMID: 33966038 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,620 results

Search Page

Filters